Addiction
-
Anthony Tennyson of Awakn Life Sciences on commercializing its addiction treatment therapeutics
In this InvestorIntel interview with host Tracy Weslosky, Awakn Life Sciences Corp.’s (NEO: AWKN | OTCQB: AWKNF) Co-Founder &…
-
Addiction may have met its match in Awakn Life Sciences therapeutics
Addiction is one of the biggest unmet medical needs globally with substance and behavioral addictions affecting a significant…
-
Anthony Tennyson of Awakn Life Sciences talks about their portfolio of revolutionary therapeutics and clinics to treat addiction
In this InvestorIntel interview with host Tracy Weslosky, Awakn Life Sciences Corp.’s (NEO: AWKN | OTCQB: AWKNF) Co-Founder &…
-
The light at the end of the tunnel for Awakn Life Sciences addiction treatment by Psychedelic therapeutics
As an investor, I like to look for companies that have tremendous leverage to success. I often write…
-
Awakn Life Sciences’ new psychedelic drug treatment for alcohol addiction moving to clinical trial
As we all know alcohol addiction is one of the worst addictions in society costing billions per year.…
-
Awakn announces first-ever study investigating ketamine in gambling addiction treatment
When we think about addiction many people think about drugs, tobacco, and alcohol addiction; but often forget about…
-
Awakn Life Sciences’ Anthony Tennyson on using researched backed psychedelic drugs and therapies to treat Alcohol Use Disorder
In a recent InvestorIntel interview, Tracy Weslosky speaks with Anthony Tennyson, CEO of Awakn Life Sciences Corp. (NEO:…
-
Anthony Tennyson on Awakn Life Sciences bringing innovation in addiction treatment to the market
In a recent InvestorIntel interview, Tracy Weslosky speaks with Anthony Tennyson, CEO of Awakn Life Sciences Corp. (NEO:…
-
Newly listed Awakn Life Sciences’ team of experts prepare a pathway to treat addiction through psychedelic medicines
One of the largest problems in our society today is substance abuse and addiction. Almost 21 million Americans…
